You are viewing the site in preview mode

Skip to main content

Correction: Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia

The Original Article was published on 18 January 2024

Correction: Microbial Cell Factories (2024) 23:25

https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12934-024-02297-1

In this article the affiliation details for Author Yasser K. Elesnawy and Marwa M. Abdelghany were swapped as ‘Ahmed Maher Teaching Hospital, Cairo, Egypt’ and ‘National Committee for Control of Viral Hepatitis (NCCVH), Ministry of Health and Population, Cairo, Egypt’.

But should have been ‘National Committee for Control of Viral Hepatitis (NCCVH), Ministry of Health and Population, Cairo, Egypt’ and ‘Ahmed Maher Teaching Hospital, Cairo, Egypt’.

The original article has been corrected.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasmine S. El-Abd.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12934-024-02297-1.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shawky, H., Tabll, A.A., Elshenawy, R.M. et al. Correction: Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia. Microb Cell Fact 23, 340 (2024). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12934-024-02622-8

Download citation

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12934-024-02622-8